INGENERON
InGeneron is a clinical stage cell therapy company. We believe that evidence-based regenerative therapy will redefine the health care experience. Its system is designed to enable doctors to heal patients safely and quickly by unlocking and using the healing potential of their own regenerative cells. Founded in 2006, we are a Houston-headquartered, privately held company that was formed to innovate cell-based technologies for health care and life science research. The work of our scientists and ... doctors in the field of the stem and regenerative cell research has enabled us to develop a regenerative cell therapy product platform for multiple potential applications. This work has yielded numerous peer-reviewed publications and studies on the use of autologous adult stem cells – those that are extracted from and reintroduced into the same person – to promote healing.
INGENERON
Industry:
Alternative Medicine Biotechnology Health Care Therapeutics
Founded:
2006-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.ingeneron.com
Total Employee:
11+
Status:
Active
Contact:
(713)440-9900
Total Funding:
51 M USD
Technology used in webpage:
Wordpress Plugins Euro Cloudflare Network Error Logging ThemePunch WordPress 5.7
Current Advisors List
Current Employees Featured
Founder
Investors List
Sanford Health
Sanford Health investment in Series D - InGeneron
Sanford Health
Sanford Health investment in Series D - InGeneron
Official Site Inspections
http://www.ingeneron.com Semrush global rank: 8.99 M Semrush visits lastest month: 227
- Host name: 104.21.64.1
- IP address: 104.21.64.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "InGeneron"
Leading Regenerative Medicine - Overview - InGeneron
InGeneron remains dedicated to evidence based clinical research while leading regenerative medicine for over a decade.See details»
InGeneron - Overview, News & Similar companies | ZoomInfo.com
InGeneron Inc. is a private multinational medical device and biotechnology company headquartered in Houston, Texas, United States, and with European headquarters in Munich, …See details»
Developing Cell-Based Therapies - InGeneron
InGeneron is a clinical-stage biotechnology company developing cell-based therapies to redefine the standard of care in orthopedics.See details»
InGeneron - Crunchbase Company Profile & Funding
InGeneron enables novel, safe, and evidence-based therapies that unlock the …See details»
InGeneron Company Overview, Contact Details & Competitors
InGeneron, Inc. received financing of $23M in Series D on Oct 31st '19. InGeneron, Inc., a clinical stage regenerative medicine and cell therapy company, announced today the extension of its …See details»
InGeneron - Products, Competitors, Financials, Employees, …
About InGeneron InGeneron is a clinical-stage biotechnology company focused on developing cell-based therapies within the healthcare sector, specifically targeting orthopedics. The …See details»
InGeneron Company Profile - Office Locations, Competitors ... - Craft
InGeneron has 5 employees across 2 locations and $47.5 m in total funding,. See insights on InGeneron including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
InGeneron Information - RocketReach
InGeneron is a Biotechnology Research, Business Services General, and Alternative Medicine company located in Houston, Texas with $4 million in revenue and 18 employees. Find top …See details»
InGeneron Inc - Company Profile and News - Bloomberg Markets
Dec 27, 2000 Company profile page for InGeneron Inc including stock price, company news, executives, board members, and contact informationSee details»
InGeneron 2025 Company Profile: Valuation, Funding …
Information on valuation, funding, cap tables, investors, and executives for InGeneron. Use the PitchBook Platform to explore the full profile.See details»
Ingeneron - Company Profile - Tracxn
Feb 22, 2025 Ingeneron - Developer of cell-separation technology for regenerative medicine. Raised a total funding of $51.4M over 5 rounds from 2 investors.See details»
InGeneron - LinkedIn
InGeneron is a clinical-stage biotechnology company developing novel, safe, and evidence-based cell therapies. We are setting new therapeutic standards by enabling minimally invasive …See details»
InGeneron - VentureRadar
InGeneron is a cell therapy company that enables novel, evidence-based treatments designed to heal certain chronic conditions using a patient’s own regenerative cells processed at the …See details»
InGeneron, Inc.:Company Profile & Technical Research,Competitor …
Discovery Company profile page for InGeneron, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Ingeneron - Overview, CEO, Products, Business - Easyleadz
Ingeneron is a private company and Ingeneron is classified as a Non Government company. Ingeneron is a Biotech based company and has headquarters in Houston, Texas, United …See details»
InGeneron - Contacts, Employees, Board Members, Advisors
InGeneron enables novel, safe, and evidence-based therapies that unlock the healing potential of each patient's own regenerative cells.See details»
InGeneron Overview | SignalHire Company Profile
InGeneron is a private company that has been in the industry for 17 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the CEO is occupied by …See details»
Our Leaders - InGeneron
Meet the dynamic leadership team at Ingeneron, guiding innovations in regenerative medicine and committed to pioneering scientific breakthroughs.See details»
InGeneron - Profiles & Contacts - Crunchbase
InGeneron enables novel, safe, and evidence-based therapies that unlock the healing potential of each patient's own regenerative cells.See details»
InGeneron Management Team | Org Chart - RocketReach
The InGeneron management team includes Fabian Alt (Chief Financial Officer), Claire Huang (Clinical Science Manager), and David Mercer (Director of Product Engineering).See details»